The Efficacy and Safety of Treatment With Telitacicept in Primary Membranous Nephropathy

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
This is a multiple-center, prospective, open-label, positive drug controlled, randomized, clinical study to evaluate the safety and efficacy of Telitacicept in the treatment of primary membranous nephropathy.
Epistemonikos ID: d4243b990afe50ce3c02f3b46cb593ede57b188d
First added on: Apr 17, 2025